Severe, life-threatening, and fatal chronic health conditions after allogeneic blood or marrow transplantation in childhood

被引:2
作者
Holmqvist, Anna Sallfors [1 ]
Chen, Yanjun [2 ]
Hageman, Lindsey [2 ]
Landier, Wendy [2 ]
Wu, Jessica [2 ]
Francisco, Liton F. [2 ]
Ross, Elizabeth Schlichting [2 ]
Balas, Nora A. [2 ]
Bosworth, Alysia [3 ]
Te, Hok Sreng [4 ]
Goldman, Frederick D. [5 ]
Rosenthal, Joseph [6 ]
Wong, F. Lennie [3 ]
Weisdorf, Daniel J. [4 ]
Armenian, Saro H. [3 ,6 ]
Bhatia, Smita [2 ,5 ,7 ]
机构
[1] Lund Univ, Skane Univ Hosp, Childhood Canc Ctr, Dept Clin Sci, Lund, Sweden
[2] Univ Alabama Birmingham, Inst Canc Outcomes & Survivorship, Sch Med, Birmingham, AL USA
[3] City Hope Natl Med Ctr, Populat Sci, Duarte, CA USA
[4] Univ Minnesota, Div Hematol Oncol & Transplantat, Minneapolis, MN USA
[5] Univ Alabama Birmingham, Div Pediat Hematol Oncol & Bone Marrow Transplanta, Birmingham, AL USA
[6] City Hope Natl Med Ctr, Pediat Hematol Oncol, Duarte, CA USA
[7] Univ Alabama Birmingham, Inst Canc Outcomes & Survivorship, Sch Med, Dept Pediat, 1600 7th Ave South, Lowder 500, Birmingham, AL 35233 USA
关键词
childhood cancer; hematopoietic stem cell transplantation; late effects; morbidity; neoplasms; pediatrics; survivorship; HEMATOPOIETIC-CELL TRANSPLANTATION; CARDIOVASCULAR RISK-FACTORS; SOLID CANCERS; SURVIVORS; BONE; CHILDREN; DISEASE; PREVALENCE; PREDICTORS; MORTALITY;
D O I
10.1002/cncr.34575
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundA comprehensive assessment of morbidity after allogeneic bone marrow transplantation (BMT) performed in childhood remains understudied. MethodsSeven hundred eighty-nine allogeneic BMT recipients who had survived >= 2 years after BMT performed between 1974 and 2014 at age <22 years and 690 siblings completed a 255-item survey self-reporting sociodemographics and chronic health conditions. A severity score (grade 3 [severe], 4 [life-threatening], or 5 [fatal]) was assigned to the conditions using Common Terminology Criteria for Adverse Events, version 5.0. For the BMT cohort, the cumulative incidence of chronic health conditions was calculated as a function of time from BMT. Proportional subdistribution hazards models were used to determine predictors of grade 3-5 conditions. Logistic regression was used to estimate the risk of grade 3-4 conditions in BMT recipients who were alive at the time of this study compared with siblings. ResultsThe median age at transplantation was 11.3 years (range, 0.4-22.0 years), and the median length of follow-up was 11.7 years (range, 2.0-45.3 years). The most prevalent primary diagnoses were acute lymphoblastic leukemia (30.7%), and acute myeloid leukemia/myelodysplastic syndrome (26.9%). At age 35 years, the cumulative incidence of a grade 3-4 condition was 53.8% (95% CI, 46.7%-60.3%). The adjusted odds ratio of a grade 3-4 condition was 15.1 in survivors (95% CI, 9.5-24.0) compared with siblings. The risk of a grade 3-5 condition increased with age at BMT (hazard ratio [HR], 1.03; 95% CI, 1.01-1.05) and was higher among females (HR, 1.27; 95% CI, 1.02-1.59), patients who received total body irradiation (HR, 1.71; 95% CI, 1.27-2.31), and those reporting chronic graft-versus-host disease (HR, 1.38; 95% CI, 1.09-1.74). ConclusionsTwo-year survivors of allogeneic BMT in childhood have an increased risk of grade 3-4 chronic health conditions compared with siblings, suggesting the need for long-term follow-up.
引用
收藏
页码:624 / 633
页数:10
相关论文
共 29 条
  • [1] Long-term outcome after allo-SCT: close follow-up on a large cohort treated with myeloablative regimens
    Abou-Mourad, Y. R.
    Lau, B. C.
    Barnett, M. J.
    Forrest, D. L.
    Hogge, D. E.
    Nantel, S. H.
    Nevill, T. J.
    Shepherd, J. D.
    Smith, C. A.
    Song, K. W.
    Sutherland, H. J.
    Toze, C. L.
    Lavoie, J. C.
    [J]. BONE MARROW TRANSPLANTATION, 2010, 45 (02) : 295 - 302
  • [2] [Anonymous], 2003, COMMON TERMINOLOGY C
  • [3] Cardiovascular risk factors in hematopoietic cell transplantation survivors: role in development of subsequent cardiovascular disease
    Armenian, Saro H.
    Sun, Can-Lan
    Vase, Tabitha
    Ness, Kirsten K.
    Blum, Emily
    Francisco, Liton
    Venkataraman, Kalyanasundaram
    Samoa, Raynald
    Wong, F. Lennie
    Forman, Stephen J.
    Bhatia, Smita
    [J]. BLOOD, 2012, 120 (23) : 4505 - 4512
  • [4] Long-term health-related outcomes in survivors of childhood cancer treated with HSCT versus conventional therapy: a report from the Bone Marrow Transplant Survivor Study (BMTSS) and Childhood Cancer Survivor Study (CCSS)
    Armenian, Saro H.
    Sun, Can-Lan
    Kawashima, Toana
    Arora, Mukta
    Leisenring, Wendy
    Sklar, Charles A.
    Baker, K. Scott
    Francisco, Liton
    Teh, Jennifer Berano
    Mills, George
    Wong, F. Lennie
    Rosenthal, Joseph
    Diller, Lisa R.
    Hudson, Melissa M.
    Oeffinger, Kevin C.
    Forman, Stephen J.
    Robison, Leslie L.
    Bhatia, Smita
    [J]. BLOOD, 2011, 118 (05) : 1413 - 1420
  • [5] Total body irradiation dose and risk of subsequent neoplasms following allogeneic hematopoietic cell transplantation
    Baker, K. Scott
    Leisenring, Wendy M.
    Goodman, Pamela J.
    Ermoian, Ralph P.
    Flowers, Mary E.
    Schoch, G.
    Storb, Rainer
    Sandmaier, Brenda M.
    Deeg, H. Joachim
    [J]. BLOOD, 2019, 133 (26) : 2790 - 2799
  • [6] New malignancies after blood or marrow stem-cell transplantation in children and adults: Incidence and risk factors
    Baker, KS
    Defor, TE
    Burns, LJ
    Ramsay, NKC
    Neglia, JP
    Robison, LL
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (07) : 1352 - 1358
  • [7] Health status of childhood leukemia survivors who received hematopoietic cell transplantation after BU or TBI: an LEA study
    Bernard, F.
    Auquier, P.
    Herrmann, I.
    Contet, A.
    Poiree, M.
    Demeocq, F.
    Plantaz, D.
    Galambrun, C.
    Barlogis, V.
    Berbis, J.
    Garnier, F.
    Sirvent, N.
    Kanold, J.
    Chastagner, P.
    Chambost, H.
    Michel, G.
    [J]. BONE MARROW TRANSPLANTATION, 2014, 49 (05) : 709 - 716
  • [8] Solid cancers after bone marrow transplantation
    Bhatia, S
    Louie, AD
    Bhatia, R
    O'Donnell, MR
    Fung, H
    Kashyap, A
    Krishnan, A
    Molina, A
    Nademanee, A
    Niland, JC
    Parker, PA
    Snyder, DS
    Spielberger, R
    Stein, A
    Forman, SJ
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (02) : 464 - 471
  • [9] High burden of late effects after haematopoietic stem cell transplantation in childhood: a single-centre study
    Bresters, D.
    van Gils, I. C. M.
    Kollen, W. J. W.
    Ball, L. M.
    Oostdijk, W.
    van der Bom, J. G.
    Egeler, R. M.
    [J]. BONE MARROW TRANSPLANTATION, 2010, 45 (01) : 79 - 85
  • [10] Incidence and predictors of delayed chronic kidney disease in long-term survivors of hematopoietic cell transplantation
    Choi, Michael
    Sun, Can-Lan
    Kurian, Seira
    Carter, Andrea
    Francisco, Liton
    Forman, Stephen J.
    Bhatia, Smita
    [J]. CANCER, 2008, 113 (07) : 1580 - 1587